• All
  • Articles
  • Squawks
  • Trade views
  • Must reads
  • Videos
  • Calendar
Write a Squawk
No posts
  • Editor’s Picks / 01 October 2014 at 12:00 GMT

    Ebola hits US, biotechs jump

    Market sentiment was down overall on confirmation of the first US Ebola case. In the biotech sector, however, heavy speculation on drugmakers researching treatments for the lethal virus saw shares rocket by as much as 24%. The biggest gainers, writes MarketWatch, were Tekmira Pharmaceuticals (TKMR), BioCryst Pharmaceuticals (BCRX) and NewLink Genetics (NLNK).
    Read article on MarketWatch
    Go to post